TLR2 deficiency attenuates skeletal muscle atrophy in mice

Dae-Sung Kim1, Hye-Na Cha2, Hye Jun Jo2

  • 1Department of Orthopedic Surgery, College of Medicine, Yeungnam University, Daegu 705-717, South Korea.

Insights

Toll-like receptor (TLR) 2 activation contributes to skeletal muscle atrophy by increasing oxidative stress and inflammation. Inhibiting TLR2 in mice attenuated muscle atrophy markers, suggesting TLR2 as a therapeutic target.

Area of Science:

  • Muscle physiology
  • Immunology
  • Molecular biology

Background:

  • Skeletal muscle atrophy is linked to oxidative stress and inflammation.
  • Toll-like receptor (TLR) 2 activation can induce oxidative stress and inflammation.
  • TLR2's direct role in skeletal muscle atrophy requires investigation.

Purpose of the Study:

  • To investigate the role of TLR2 in skeletal muscle atrophy.
  • To compare skeletal muscle atrophy in wild-type (WT) and TLR2 knockout (KO) mice.

Main Methods:

  • Mice (WT and TLR2 KO) underwent immobilization for 2 weeks.
  • Skeletal muscle was analyzed for cytokine gene expression, protein carbonylation, nitrotyrosine, and ubiquitinated proteins.
  • Muscle weight, running times, and key atrophy-related proteins (FOXO1/3, atrogin-1, MuRF1) were assessed.
  • Cardiotoxin-induced muscle injury model was used to further evaluate TLR2's role.

Main Results:

  • Immobilization increased atrophy markers in WT mice, with attenuated increases in TLR2 KO mice.
  • Muscle weight loss and reduced running times were less severe in TLR2 KO mice.
  • TLR2 deficiency reduced immobilization-induced increases in atrophy-related proteins and ubiquitinated proteins.
  • Cardiotoxin-induced increases in atrogin-1, IL-6, and nitrotyrosine were lower in TLR2 KO mice.

Conclusions:

  • TLR2 plays a significant role in skeletal muscle atrophy.
  • TLR2 inhibition may be a viable strategy for preventing muscle atrophy.